Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 31:2021:9999146.
doi: 10.1155/2021/9999146. eCollection 2021.

Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease

Affiliations
Review

Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease

Rodolfo Kölliker-Frers et al. Mediators Inflamm. .

Abstract

The concept of central nervous system (CNS) inflammation has evolved over the last decades. Neuroinflammation is the response of reactive CNS components to altered homeostasis, regardless of the cause to be endogenous or exogenous. Neurological diseases, whether traumatic, neoplastic, ischemic, metabolic, toxic, infectious, autoimmune, developmental, or degenerative, involve direct and indirect immune-related neuroinflammation. Brain infiltrates of the innate and adaptive immune system cells appear in response to an infective or otherwise noxious agent and produce inflammatory mediators. Mediators of inflammation include local and recruited cells and signals. Processes derived from extrinsic and intrinsic CNS diseases also elicit the CNS inflammatory response. A deeper understanding of immune-related inflammation in health and disease is necessary to find potential therapeutic targets for preventing or reducing CNS damage. This review is aimed at discussing the innate and adaptive immune system functions and their roles in regulating brain cell responses in disease and homeostasis maintenance.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Essential ways cytokines affect the brain. (1) De novo synthesis of cytokines in the CNS in homeostatic conditions is clear. (2) Peripheral cytokines can induce brain cytokine synthesis. Also, cytokines can act centrally via endothelial cells. Cytokine-endothelial cell interaction triggers the release of second messengers like nitric oxide (NO) and prostaglandins (PGS) with central effects. Hence, the signal mediated by a cytokine as IL-1β can be transduced from the periphery without crossing the BBB. (3) Systemic administration of IL-1β and TNF-α to experimental animals decreases BBB selectivity. Cytokines induce glial stimulation.
Figure 2
Figure 2
Schematic representation of ATIA as the proposed inflammation and hypoxia crossover.
Figure 3
Figure 3
Schematic representation of parenchyma and macrophage cell fate in hypoxia and oxidative stress-inflammation environment.
Figure 4
Figure 4
Hypoxic and nonhypoxic inflammation and neuroimmune interactions involved in the prohemostatic response in the CNS. Brain parenchyma, the functional tissue, comprises neurons and glia cells. Brain damage or trauma often leads to cognitive deterioration and/or motor disability with parenchyma structural alterations and eventual cell death. Triggering (1) nonhypoxic and (2) hypoxic reactive inflammation might subserve functional postinjury recovery. Oxidative stress by a high oxygen level induces a compensatory antioxidant response to cut out damage progression. At the other end, hypoxia (hypoxic stress) by a low oxygen level upregulates pathways involved in boosting the oxygen supply. In any case, a fault in oxygen homeostasis draws inflammation with immune cell infiltrates and resident glial cells to restore homeostasis. Light-blue arrow: regulation; red arrow: stimulation.
Figure 5
Figure 5
Complexity of brain cell interactions in scar formation and repair.

References

    1. Miller R. J., Rostene W., Apartis E., et al. Chemokine action in the nervous system. Journal of Neuroscience. 2008;28(46):11792–11795. doi: 10.1523/JNEUROSCI.3588-08.2008. - DOI - PMC - PubMed
    1. Gimsa U., Mitchison N. A., Brunner-Weinzierl M. C. Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation. Mediators of Inflammation. 2013;2013:11. doi: 10.1155/2013/320519.320519 - DOI - PMC - PubMed
    1. Fernandez H., Cevallos A., Jimbo Sotomayor R., Naranjo-Saltos F., Mera Orces D., Basantes E. Mental disorders in systemic lupus erythematosus: a cohort study. Rheumatology International. 2019;39(10):1689–1695. doi: 10.1007/s00296-019-04423-4. - DOI - PubMed
    1. Abd-Ellatief R. B., Mohamed H. K., Kotb H. I. Reactive astrogliosis in an experimental model of fibromyalgia: effect of dexmedetomidine. Cells, Tissues, Organs. 2018;205(2):105–119. doi: 10.1159/000488757. - DOI - PubMed
    1. Alonso R., Fernández-Fernández A. M., Pisa D., Carrasco L. Multiple sclerosis and mixed microbial infections. Direct identification of fungi and bacteria in nervous tissue. Neurobiology of Disease. 2018;117:42–61. doi: 10.1016/j.nbd.2018.05.022. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources